Skip to main content
Top
Published in: International Ophthalmology 6/2013

01-12-2013 | Original Paper

Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion

Authors: Hidetaka Noma, Katsunori Shimada, Tatsuya Mimura

Published in: International Ophthalmology | Issue 6/2013

Login to get access

Abstract

The influence of retinal ischemia on changes of visual acuity, macular sensitivity, macular thickness, and macular volume is unclear after pars plana vitrectomy (PPV) for macular edema with branch retinal vein occlusion (BRVO). Twenty-three patients (23 eyes) with BRVO and macular edema underwent PPV. Retinal ischemia was evaluated from capillary non-perfusion on fluorescein angiography, and patients were classified as ischemic or nonischemic. Microperimetry was performed with a Micro Perimeter 1. Macular thickness and volume were measured by optical coherence tomography. Mean macular thickness within the central 4°, 10°, and 20° fields decreased significantly from before to 3 and 6 months after PPV (all P < 0.001). Likewise, total macular volume within the central 4°, 10°, and 20° fields decreased significantly from before to 3 and 6 months after PPV (all P < 0.001). Best-corrected visual acuity (BCVA) improved significantly from before to 3 and 6 months after PPV (P < 0.001). Furthermore, mean macular sensitivity within the central 4°, 10°, and 20° fields increased significantly from before to 3 and 6 months after PPV (P = 0.002, P = 0.001, and P = 0.001, respectively). There were no significant differences in the trend profiles of macular thickness, macular volume, and BCVA between the ischemic and nonischemic groups. However, there was a significant difference in the trend profile of macular sensitivity within the central 4°, 10°, and 20° fields between the ischemic and nonischemic groups (P = 0.017, P = 0.010 and P = 0.025, respectively). These findings suggest PPV may be more effective for improving macular sensitivity in ischemic than nonischemic BRVO.
Literature
1.
go back to reference Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM (1996) Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 103:551–560PubMedCrossRef Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM (1996) Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 103:551–560PubMedCrossRef
2.
go back to reference Noma H, Funatsu H, Sakata K et al (2009) Macular microcirculation and macular oedema in branch retinal vein occlusion. Br J Ophthalmol 93:630–633PubMedCrossRef Noma H, Funatsu H, Sakata K et al (2009) Macular microcirculation and macular oedema in branch retinal vein occlusion. Br J Ophthalmol 93:630–633PubMedCrossRef
3.
go back to reference Noma H, Funatsu H, Yamasaki M et al (2005) Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140:256–261PubMed Noma H, Funatsu H, Yamasaki M et al (2005) Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140:256–261PubMed
4.
go back to reference Noma H, Minamoto A, Funatsu H et al (2006) Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244:309–315PubMedCrossRef Noma H, Minamoto A, Funatsu H et al (2006) Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244:309–315PubMedCrossRef
5.
go back to reference Noma H, Funatsu H, Yamasaki M et al (2008) Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22:42–48PubMedCrossRef Noma H, Funatsu H, Yamasaki M et al (2008) Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22:42–48PubMedCrossRef
6.
go back to reference Kriechbaum K, Michels S, Prager F et al (2008) Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol 92:518–522PubMedCrossRef Kriechbaum K, Michels S, Prager F et al (2008) Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol 92:518–522PubMedCrossRef
7.
go back to reference Prager F, Michels S, Kriechbaum K et al (2009) Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 93:452–456PubMedCrossRef Prager F, Michels S, Kriechbaum K et al (2009) Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 93:452–456PubMedCrossRef
8.
go back to reference Brown DM, Campochiaro PA, Bhisitkul RB et al (2011) Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 118:1594–1602PubMedCrossRef Brown DM, Campochiaro PA, Bhisitkul RB et al (2011) Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 118:1594–1602PubMedCrossRef
9.
go back to reference Scott IU, Ip MS, VanVeldhuisen PC et al (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol 127:1115–1128PubMedCrossRef Scott IU, Ip MS, VanVeldhuisen PC et al (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol 127:1115–1128PubMedCrossRef
10.
go back to reference The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98:271–282 The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98:271–282
11.
go back to reference Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E (2007) Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 27:49–54PubMedCrossRef Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E (2007) Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 27:49–54PubMedCrossRef
12.
go back to reference Yamaike N, Kita M, Tsujikawa A, Miyamoto K, Yoshimura N (2007) Perimetric sensitivity with the micro perimeter 1 and retinal thickness in patients with branch retinal vein occlusion. Am J Ophthalmol 143:342–344PubMedCrossRef Yamaike N, Kita M, Tsujikawa A, Miyamoto K, Yoshimura N (2007) Perimetric sensitivity with the micro perimeter 1 and retinal thickness in patients with branch retinal vein occlusion. Am J Ophthalmol 143:342–344PubMedCrossRef
13.
go back to reference Yamaike N, Tsujikawa A, Sakamoto A et al (2009) Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Retina 29:757–767PubMedCrossRef Yamaike N, Tsujikawa A, Sakamoto A et al (2009) Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Retina 29:757–767PubMedCrossRef
14.
go back to reference Noma H, Funatsu H, Mimura T, Harino S, Shimada K (2011) Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema. Retina 31:2102–2108PubMedCrossRef Noma H, Funatsu H, Mimura T, Harino S, Shimada K (2011) Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema. Retina 31:2102–2108PubMedCrossRef
15.
go back to reference Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ (2008) Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 246:1241–1247PubMedCrossRef Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ (2008) Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 246:1241–1247PubMedCrossRef
16.
go back to reference Kirchhoff AC, Drum ML, Zhang JX et al (2008) Hypertension and hyperlipidemia management in patients treated at community health centers. J Clin Outcomes Manag 15:125–131PubMed Kirchhoff AC, Drum ML, Zhang JX et al (2008) Hypertension and hyperlipidemia management in patients treated at community health centers. J Clin Outcomes Manag 15:125–131PubMed
17.
go back to reference Battaglia Parodi M, Saviano S, Ravalico G (1999) Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 237:1024–1027PubMedCrossRef Battaglia Parodi M, Saviano S, Ravalico G (1999) Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 237:1024–1027PubMedCrossRef
18.
go back to reference Branch Vein Occlusion Study Group (1986) Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol 104:34–41CrossRef Branch Vein Occlusion Study Group (1986) Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol 104:34–41CrossRef
19.
go back to reference Stefansson E, Novack RL, Hatchell DL (1990) Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 31:284–289PubMed Stefansson E, Novack RL, Hatchell DL (1990) Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 31:284–289PubMed
20.
go back to reference Stefansson E (2006) Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol 51:364–380PubMedCrossRef Stefansson E (2006) Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol 51:364–380PubMedCrossRef
21.
go back to reference Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K (2011) Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion. Clin Ophthalmol 5:223–229PubMedCrossRef Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K (2011) Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion. Clin Ophthalmol 5:223–229PubMedCrossRef
22.
go back to reference Okunuki Y, Usui Y, Katai N et al (2011) Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion. Am J Ophthalmol 151:610–616 e1PubMed Okunuki Y, Usui Y, Katai N et al (2011) Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion. Am J Ophthalmol 151:610–616 e1PubMed
23.
go back to reference Hogan MJ, Alvarado JA, Weddell JE (1971) Histology of the human eye: an atlas and textbook. Saunders, Philadelphia 492 Hogan MJ, Alvarado JA, Weddell JE (1971) Histology of the human eye: an atlas and textbook. Saunders, Philadelphia 492
24.
go back to reference Noma H, Funatsu H, Mimura T, Shimada K (2012) Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. Retina 32:1844–1852PubMedCrossRef Noma H, Funatsu H, Mimura T, Shimada K (2012) Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. Retina 32:1844–1852PubMedCrossRef
25.
go back to reference Otani T, Yamaguchi Y, Kishi S (2004) Serous macular detachment secondary to distant retinal vascular disorders. Retina 24:758–762PubMedCrossRef Otani T, Yamaguchi Y, Kishi S (2004) Serous macular detachment secondary to distant retinal vascular disorders. Retina 24:758–762PubMedCrossRef
26.
go back to reference Tsujikawa A, Sakamoto A, Ota M et al (2010) Serous retinal detachment associated with retinal vein occlusion. Am J Ophthalmol 149:291–301 e295PubMedCrossRef Tsujikawa A, Sakamoto A, Ota M et al (2010) Serous retinal detachment associated with retinal vein occlusion. Am J Ophthalmol 149:291–301 e295PubMedCrossRef
27.
go back to reference Noma H, Funatsu H, Shimada K, Mimura T (2013) Influence of pars plana vitrectomy on macular sensitivity and morphology in patients with branch retinal vein occlusion and serous retinal detachment. Ophthalmic Surg Lasers Imaging Retina 44:160–167PubMedCrossRef Noma H, Funatsu H, Shimada K, Mimura T (2013) Influence of pars plana vitrectomy on macular sensitivity and morphology in patients with branch retinal vein occlusion and serous retinal detachment. Ophthalmic Surg Lasers Imaging Retina 44:160–167PubMedCrossRef
Metadata
Title
Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion
Authors
Hidetaka Noma
Katsunori Shimada
Tatsuya Mimura
Publication date
01-12-2013
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 6/2013
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-013-9762-2

Other articles of this Issue 6/2013

International Ophthalmology 6/2013 Go to the issue